Login to Your Account

Financings Roundup

Epizyme Files for IPO, Aims for $69M for Epigenetics Platform

By Jennifer Boggs
Managing Editor

Monday, April 29, 2013
Epizyme Inc., the latest biotech to take advantage of the emerging growth company provision in last year's JOBS Act, filed an S-1 Friday for a proposed $69 million initial public offering (IPO), though the number of shares and share price have not yet been disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription